Pancreatic Cancer Research

ResearcherNanjing Drum Tower HospitalNo recent work listed

Zhan Shi

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer. First author DOI 10.1080/21645515.2023.2178791↗
  2. Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic… Co-author DOI 10.3389/fonc.2022.782730↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Changchang Lu · 2 shared papers, 2022–2023 · strength 0.34
  2. Juan Du · 2 shared papers, 2022–2023 · strength 0.34
  3. Xin Qiu · 2 shared papers, 2022–2023 · strength 0.34
  4. Baorui Liu · 2 shared papers, 2022–2023 · strength 0.34
  5. Qiao-Li Wang · 1 shared paper, 2023 · strength 0.17
  6. Fan Tong · 1 shared paper, 2023 · strength 0.17
  7. Juan Liu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.